Mark your calendars! The Summit for Cancer Immunotherapy (Summit4CI), BioCanRx’s sixth scientific conference, is happening this November 19-21, 2022, in the heart of Montréal at Fairmont The Queen Elizabeth Hotel.
Join more than 300 scientists, clinicians, research students, economists, industry and patient representatives, along with charity and government groups to discuss the latest advances in cancer immunotherapy.
This year’s agenda features distinguished keynote speaker, Dr. Carl H. June, the Richard W. Vague Professor in Immunotherapy, Director of the Center for Cellular Immunotherapies and Director of the Parker Institute for Cancer Immunotherapy in the Perelman School of Medicine at the University of Pennsylvania. Summit4CI plenary topics include:
- Applications of Synthetic Biology & Next Generation Engineering Strategies
- Cancer Immunotherapy and the Microbiome
- Debate – Mutations, Metabolome or Microbiome: Who’s Running the Immunology in a Tumour?
- Adoptive Cell Immunotherapy: Current State and (some) Future Directions
- What’s the Endgame for Cancer Immunotherapy in Canada?
The Learning Institute is back. It brings together leaders from oncology patient communities and academics from the immunotherapy research community. Participants attend all plenaries, engage in knowledge exchange activities and take part in a Patient-Researcher Roundtable event.
For those looking to make connections, there will be ample networking opportunities, from a fun social night to lunches and coffee breaks, and of course, the opening evening reception and dinner.
We hope you’ll join us in Montréal! Registration will open in July. Stay tuned to cancersummit.ca for updates.
